India has both - a domestic pharmaceuticals market growing faster than 20% and a globally recognized manufacturing capacity for export to both regulated and unregulated markets. The pharmaceutical industry is the cornerstone of the healthcare sector with the established generic companies having achieved success at a large scale. Over the last 30 years Sathguru has advised several of the leading pharmaceutical companies on market strategies, access to product and platform technologies and has fueled growth plans through fund raising and mergers and acquisitions
The domestic pharmaceutical market now demands innovation in products and delivery. Economic growth and consequent willingness to pay continues to fuel growth in this largely out of pocket payment market. Disease profile has been evolving with greater incidence of lifestyle diseases such as diabetes and cardiovascular and there is greater convergence with western disease profiles. Indian companies now have now expanded focus from process innovation to product innovation and have enhanced focus on building their product portfolios. Leading market players are now leveraging their deep expertise in chemistry to establish themselves in emerging opportunity areas such as peptides and novel formulation platforms.
Our combination of business, finance and innovation advisory has uniquely positioned us as an end-to-end advisor and partner to the pharmaceutical and biotech sectors. We catalyze success for global clients through domestic market entry, portfolio optimization and strategic partnerships and for Indian clients through strategic growth planning, product and technology access for strengthening portfolios, global market access and growth. Finally, we work with policy makers to contribute the evolving policy environment, handhold ventures to accelerate product commercialization and work with innovation and corporate funders to advise them on investment opportunities. Talk to us about how we can help you establish and grow.